Glenmark Pharmaceuticals has informed regarding a Press Release dated April 10, 2015, titled ‘Glenmark Generics receives ANDA approval for Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.09 mg/0.02 mg’
The above information is a part of company’s filings submitted to BSE.